Filing Flows › Indivior Pharmaceuticals (INDV) › Free cash flow
Indivior Pharmaceuticals (INDV) free cash flow by quarter
Indivior Pharmaceuticals' free cash flow was $83.0M in Q3 2026 (third quarter 2026), -63% from Q2 2026. Over the last 4 quarters it ranged from $70.0M (Q1 2025) to $222M (Q2 2026).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $83.0M | -63% | — |
| Q2 2026 | $222M | +57% | +57% |
| Q2 2025 | $141M | +101% | — |
| Q1 2025 | $70.0M | — | — |
Q3 2026 at a glance
Indivior Pharmaceuticals, Q3 2026: revenue $356M (+13% year over year), operating margin 50.6%, net earnings $137M, operating cash flow $97.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is Indivior Pharmaceuticals' free cash flow?
Indivior Pharmaceuticals' free cash flow was $83.0M in Q3 2026 (third quarter 2026), -63% from Q2 2026.
How has Indivior Pharmaceuticals' free cash flow changed?
Over the last 4 quarters it ranged from $70.0M (Q1 2025) to $222M (Q2 2026).
Q3 2026 results → · How Indivior Pharmaceuticals makes money →